FindTrial
Sign In

Treating PCOS using Darchini

Efficacy of hydroalcoholic extract of Darchini (Cinnamomum zeylanicum) in the management of Polycystic Ovarian Syndrome. A randomized control study - PCOS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061574
Enrollment
90
Registered
2024-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Hydroalcoholic extract of Drachini: 200 Mg Capsule Twice Daily For Two Months Intervention2: Darchini Powder: 3 gm Capsule in two divided doses daily for two months Control Intervention

Sponsors

Department Of Amraz e Niswan Wa Qabalat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married or unmarried females. Patients who have PCOS diagnosed via Rotterdam criteria.

Exclusion criteria

Exclusion criteria: PREGNANT AND LACTATING MOTHERS PATIENT ON HORMONAL THERAPY GROSS PELVIC PATHOLOGY AND MALIGNANCY UNCONTROLLED HYPERTENSION DIABETES MELLITUS THYROID DYSFUNCTION

Design outcomes

Primary

MeasureTime frame
Change in serum insulin level, Change in fasting blood sugar, Change in OGTT AMELIORATION OF POLYCYSTIC OVARIES ON USG.Timepoint: 2 months with followup after every 15 days—

Secondary

MeasureTime frame
Change in BMI & change in waist hip ratioTimepoint: 2 months with followup after every 15 days—

Countries

India

Contacts

Public ContactZeba Saleem

Department Of Amraz e Niswan Wa Qabalat, Ajmal Khan Tibbiya College, AMU, Aligarh, U.P., India

abihaahmad89@gmail.com9620551870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026